Increased Incidence of C. difficile in Travelers Returning Home


C. difficile infections in travelers returning home could be a cause of travel-associated diarrhea.

The spike in Clostridium difficile (C. difficile) infections found in travelers returning from international destinations could be a cause of travel-associated diarrhea, according to a new report.

Researchers from the University of Utah School of Medicine analyzed and summarized the demographic and travel-associated and geographic characteristics of travelers with C. difficile infection. The team identified 260 patients between 1997 and 2015 from GeoSentinal records, of which 187 satisfied analysis criteria. GeoSentinal is a network of 59 travel and tropical medicine clinics across 6 continents, the study authors noted.

Patients were included in the analysis if they had confirmed C. difficile cases, were not immigrants, older than 2-years-old, and seen less than 12 weeks after returning from travel.

The investigators noted that there has been a better understanding of the contribution of community-acquired C. difficile infections to the global burden of the disease. However, because the epidemiology of infection among travelers wasn’t fully understood, they wanted to further understand the factors linked to international travel and how it puts travelers at risk.

Some of these varying factors included antibiotic use (a common self treatment for presumptive traveler’s diarrhea) and changes in the gut microbiota, the study authors wrote.

The study authors also discussed a previously published meta-analysis, a review of 48 published cases of travel-related C. difficile infection, which found that the majority of cases acquired their infections in low or medium income countries. Those patients also tended to be younger than 60 years of age and were community rather than hospital acquired cases.

However, in their study, the researchers determined that there was an increased reported number of infections over time — it was parallel to the rise in reported cases of giardiasis, cryptosporidiosis, and campylobacteriosis in the same time period. For example, there were nine in 1997, 31 in 2006, and 56 at the end of the study in 2015. This also reflected the growth in the GeoSentinel network, the researchers explained.

Two thirds of the travelers with C. difficile infection were female and their ages ranged from 6 to 89 years — the average age was 34 years. Most of the diagnoses for C. difficile infection were made in North American clinics: 31% in the US and 20% in Canada. The remaining diagnoses came from Europe, specifically Germany, France, and Sweden.

A majority of the travelers (62%) were traveling for tourism reasons. Other reasons included missionary, volunteer, research, or aid work (17%), business travel (11%), followed by student (6%) and visiting friends and/ or relatives (5%). The average travel time was about three weeks.

A third of the travelers were from Asia, a third were the Americas (mostly South and Central America), and a quarter was from Africa. Some travelers also came from Europe, the Middle East, and the Pacific, but it was less common.

The researchers acknowledged that nearly all regions of the world were represented as destinations from which travelers returned, along with their infection. However, the study authors noted they were unable to determine the timing of infection acquisition within their study.

The study, titled “Clostridium difficile infection in returning travelers,” was published in the May issue of the Journal of Travel Medicine.

Related Coverage:

Frail Patients At Risk For C. difficile Colonization

Minimizing Clostridium difficile Exposure Using Disposable Commode Pails

Discovering the Risk Factors for Pediatric C difficile Infection

Related Videos
Edward V Loftus, Jr, MD | Credit: Mayo Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Anthony Lembo, MD | Credit: Cleveland Clinic
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Ali Rezaie, MD | Credit: X
Remo Panaccione, MD | Credit: University of Calgary
Francisca Joly, MD, PhD | Credit: The Transplantation Society
© 2024 MJH Life Sciences

All rights reserved.